United States · Biotechnology startup
United States · Legend Biotech
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Funding reportedLast round: Post ipo equity
Follow Legend Biotech and see its new rounds in your feed.Start following
What company datasets say Legend Biotech raised
Funding, as reported
Reported in all$750Min dollars
Rounds3
Last roundPost ipo equity
Last round dateMay 2023
Investors listed5
Founders and team
From Legend Biotech's own website and the SEC filings it signed: 9 on the team.
- Ingrid ZhangChief Executive Officer
- Birk VanderweeënSenior Vice President, Global Manufacturing & Supply
- Elaine QianVice President, Global Head Of Human Resources
- Alan BashPresident of CARVYKTI®
- Carlos SantosChief Financial Officer
- Ananda MartinGlobal Compliance Officer
- Robert StaloffGeneral Counsel
- Lori MacomberExecutive Officeri
- Ying HuangExecutive Officer, Directori
On the board, as filediCorazon D. SandersDarren Xiaohui JiFangliang ZhangLi Wai Man MaoLi ZhuPatrick Wai Man CaseyPhilip Wai Man YauYe Wang
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Legend Biotech in front of investors. Or tell us what we have wrong.